Advanced search
Publication Cover
Biomarkers in Medicine Volume 1, 2007 - Issue 4
Submit an article Journal homepage
228
Views
0
CrossRef citations to date
0
Altmetric
Review

High-Throughput and Targeted in-Depth Mass Spectrometry-Based Approaches for Biofluid Profiling and Biomarker Discovery

Connie R Jimenez1 OncoProteomics Laboratory,Department of Medical Oncology,VUmc Cancer Center Amsterdam,VU University Medical Center,Amsterdam,The Netherlands.Correspondence[email protected] [email protected] [email protected]
,
Sander Piersma1 OncoProteomics Laboratory,Department of Medical Oncology,VUmc Cancer Center Amsterdam,VU University Medical Center,Amsterdam,The Netherlands.
&
Thang V Pham1 OncoProteomics Laboratory,Department of Medical Oncology,VUmc Cancer Center Amsterdam,VU University Medical Center,Amsterdam,The Netherlands.
Pages 541-565 | Published online: 17 Dec 2007

Bibliography

  • Aebersold R , MannM: Mass spectrometry-based proteomics.Nature422(6928), 198–207 (2003).
  • Qian WJ , JacobsJM, LiuT, CampDG, SmithRD: Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.Mol. Cell Proteomics5(10), 1727–1744 (2006).
  • McDonald WH , YatesJRIII: Shotgun proteomics: integrating technologies to answer biological questions.Curr. Opin. Mol. Ther.5(3), 302–309 (2003).
  • Hanash S : Disease proteomics.Nature422(6928), 226–232 (2003).
  • Hu S , LooJA, WongDT: Human body fluid proteome analysis.Proteomics6(23), 6326–6353 (2006).
  • Petricoin EF , BellucoC, AraujoRP, LiottaLA: The blood peptidome: a higher dimension of information content for cancer biomarker discovery.Nat. Rev. Cancer6(12), 961–967 (2006).
  • Anderson NL , AndersonNG: The human plasma proteome: history, character, and diagnostic prospects.Mol. Cell Proteomics1(11), 845–867 (2002).
  • Lee HJ , LeeEY, KwonMS, PaikYK: Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.Curr. Opin. Chem. Biol.10(1), 42–49 (2006).
  • Huang L , HarvieG, FeitelsonJSet al.: Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis.Proteomics5(13), 3314–3328 (2005).
  • Liu T , QianWJ, MottazHMet al.: Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.Mol. Cell Proteomics5(11), 2167–2174 (2006).
  • Adkins JN , VarnumSM, AuberryKJet al.: Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry.Mol. Cell Proteomics1(12), 947–955 (2002).
  • Veenstra TD : Global and targeted quantitative proteomics for biomarker discovery.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.847(1), 3–11 (2007).
  • Chertov O , SimpsonJT, BiragynA, ConradsTP, VeenstraTD, FisherRJ: Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery.Expert Rev. Proteomics2(1), 139–145 (2005).
  • Villanueva J , TempstP: OvaCheck: let‘s not dismiss the concept.Nature430(7000), 611 (2004).
  • Zhang H , LiuAY, LoriauxPet al.: Mass spectrometric detection of tissue proteins in plasma.Mol. Cell Proteomics6(1), 64–71 (2007).
  • Issaq HJ , ConradsTP, PrietoDA, TirumalaiR,VeenstraTD: SELDI-TOF MS for diagnostic proteomics.Anal. Chem.75(7), 148A–155A (2003).
  • Petricoin EF , LiottaLA: SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.Curr. Opin. Biotechnol.15(1), 24–30 (2004).
  • Hortin GL : The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.Clin. Chem.52(7), 1223–1237 (2006).
  • Villanueva J , PhilipJ, EntenbergDet al.: Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry.Anal. Chem.76(6), 1560–1570 (2004).
  • Baumann S , CeglarekU, FiedlerGM, LembckeJ, LeichtleA, ThieryJ: Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Clin. Chem.51(6), 973–980 (2005).
  • West-Nielsen M , HogdallEV, MarchioriE, HogdallCK, SchouC, HeegaardNH: Sample handling for mass spectrometric proteomic investigations of human sera.Anal. Chem.77(16), 5114–5123 (2005).
  • Jimenez CR, El Filali Z, Knol JC et al.: Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS. Prot. Clin. Applic.1(6), 598–604 (2007).
  • Albrethsen J : Reproducibility in protein profiling by MALDI-TOF mass spectrometry.Clin. Chem.53(5), 852–858 (2007).
  • Koomen JM , LiD, XiaoLCet al.: Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.J. Proteome Res.4(3), 972–981 (2005).
  • Rai AJ , StemmerPM, ZhangZet al.: Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.Proteomics5(13), 3467–3474 (2005).
  • Semmes OJ , FengZ, AdamBLet al.: Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.Clin. Chem.51(1), 102–112 (2005).
  • Villanueva J , PhilipJ, DeNoyerL, TempstP: Data analysis of assorted serum peptidome profiles.Nat. Protoc.2(3), 588–602 (2007).
  • Villanueva J , LawlorK, Toledo-CrowR, TempstP: Automated serum peptide profiling.Nat. Protoc.1(2), 880–891 (2006).
  • Ferguson RE , HochstrasserDF, BanksRE: Impact of preanalytical variables on the analysis of biological fluids in proteomic studies.Prot. Clin. Applic.1(8), 739–746 (2007).
  • Petricoin EF , ArdekaniAM, HittBAet al.: Use of proteomic patterns in serum to identify ovarian cancer.Lancet359(9306), 572–577 (2002).
  • Diamandis EP : Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.Cancer Res.66(11), 5540–5541 (2006).
  • Diamandis EP : Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.Mol. Cell Proteomics3(4), 367–378 (2004).
  • Jimenez CR , Koel-SimmelinkM, PhamTVet al.: Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: optimization of magnetic bead-based peptide capture and analysis of pre-analytical variables.Prot. Clin. Applic. (2007) (In press).
  • Ransohoff DF : Lessons from controversy: ovarian cancer screening and serum proteomics.J. Natl Cancer Inst.97(4), 315–319 (2005).
  • Ransohoff DF : Bias as a threat to the validity of cancer molecular-marker research.Nat. Rev. Cancer5(2), 142–149 (2005).
  • Drake SK , BowenRA, RemaleyAT, HortinGL: Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides.Clin. Chem.50(12), 2398–2401 (2004).
  • Banks RE , StanleyAJ, CairnsDAet al.: Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry.Clin. Chem.51(9), 1637–1649 (2005).
  • Villanueva J , PhilipJ, ChaparroCAet al.: Correcting common errors in identifying cancer-specific serum peptide signatures.J. Proteome Res.4(4), 1060–1072 (2005).
  • Fiedler GM , BaumannS, LeichtleAet al.: Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Clin. Chem.53(3), 421–428 (2007).
  • Jimenez CR , LiKW, DreisewerdKet al.: Pattern changes of pituitary peptides in rat after salt-loading as detected by means of direct, semiquantitative mass spectrometric profiling.Proc. Natl Acad. Sci. USA94(17), 9481–9486 (1997).
  • Jimenez CR , BurlingameAL: Ultramicroanalysis of peptide profiles in biological samples using MALDI mass spectrometry.Exp. Nephrol.6(5), 421–428 (1998).
  • Omenn GS : Strategies for plasma proteomic profiling of cancers.Proteomics6(20), 5662–5673 (2006).
  • Liotta LA , PetricoinEF: Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.J. Clin. Invest.116(1), 26–30 (2006).
  • Villanueva J , ShafferDR, PhilipJet al.: Differential exoprotease activities confer tumor-specific serum peptidome patterns.J. Clin. Invest.116(1), 271–284 (2006).
  • Lopez MF , MikulskisA, KuzdzalSet al.: A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.Clin. Chem.53(6), 1067–1074 (2007).
  • Lopez MF , MikulskisA, KuzdzalSet al.: High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.Clin. Chem.51(10), 1946–1954 (2005).
  • Lowenthal MS , MehtaAI, FrogaleKet al.: Analysis of albumin-associated peptides and proteins from ovarian cancer patients.Clin. Chem.51(10), 1933–1945 (2005).
  • Tirumalai RS , ChanKC, PrietoDA, IssaqHJ,ConradsTP,VeenstraTD: Characterization of the low molecular weight human serum proteome.Mol. Cell Proteomics2(10), 1096–1103 (2003).
  • Ruetschi U , RosenA, KarlssonGet al.: Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.J. Proteome Res.4(6), 2236–2242 (2005).
  • Yuan X , DesiderioDM: Proteomics analysis of human cerebrospinal fluid.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.815(1–2), 179–189 (2005).
  • Davidsson P , SjogrenM: The use of proteomics in biomarker discovery in neurodegenerative diseases.Dis. Markers21(2), 81–92 (2005).
  • Simonsen AH , McGuireJ, PodustVNet al.: Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer‘s disease.Neurobiol. Aging (2007) (Epub ahead of print).
  • West-Norager M , KelstrupCD, SchouC, HogdallEV, HogdallCK, HeegaardNH: Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.847(1), 30–37 (2007).
  • Domon B , AebersoldR: Mass spectrometry and protein analysis.Science312(5771), 212–217 (2006).
  • Ong SE , MannM: Stable isotope labeling by amino acids in cell culture for quantitative proteomics.Methods Mol. Biol.359, 37–52 (2007).
  • Ong SE , BlagoevB, KratchmarovaIet al.: Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.Mol. Cell Proteomics1(5), 376–386 (2002).
  • Gygi SP , RistB, GerberSA, TurecekF, GelbMH,AebersoldR: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.Nat. Biotechnol.17(10), 994–999 (1999).
  • Aggarwal K , ChoeLH, LeeKH: Shotgun proteomics using the iTRAQ isobaric tags.Brief Funct. Genomic Proteomic5(2), 112–120 (2006).
  • Washburn MP , UlaszekR, DeciuC, SchieltzDM, Yates JRIII: Analysis of quantitative proteomic data generated via multidimensional protein identification technology.Anal. Chem.74(7), 1650–1657 (2002).
  • May D , FitzgibbonM, LiuYet al.: A platform for accurate mass and time analyses of mass spectrometry data.J. Proteome Res.6(7), 2685–2694 (2007).
  • Zhang B , VerBerkmoesNC, LangstonMA, UberbacherE, HettichRL, SamatovaNF: Detecting differential and correlated protein expression in label-free shotgun proteomics.J. Proteome Res.5(11), 2909–2918 (2006).
  • Old WM , Meyer-ArendtK, veline-WolfLet al.: Comparison of label-free methods for quantifying human proteins by shotgun proteomics.Mol. Cell Proteomics4(10), 1487–1502 (2005).
  • Wiener MC , SachsJR, DeyanovaEG, YatesNA: Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures.Anal. Chem.76(20), 6085–6096 (2004).
  • Radulovic D , JelvehS, RyuSet al.: Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry.Mol. Cell Proteomics3(10), 984–997 (2004).
  • Leptos KC , SarracinoDA, JaffeJD, KrastinsB, ChurchGM: MapQuant: open-source software for large-scale protein quantification.Proteomics6(6), 1770–1782 (2006).
  • Katajamaa M , MiettinenJ, OresicM: MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data.Bioinformatics22(5), 634–636 (2006).
  • Bellew M , CoramM, FitzgibbonMet al.: A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics22(15), 1902–1909 (2006).
  • Kohlbacher O , ReinertK, GroplCet al.: TOPP – the OpenMS proteomics pipeline. Bioinformatics23(2), E191–E197 (2007).
  • Codrea MC , JimenezCR, HeringaJ, MarchioriE: Tools for computational processing of LC-MS datasets: a user‘s perspective.Comput. Methods Programs Biomed.86(3), 281–290 (2007).
  • Jaffe JD , ManiDR, LeptosKC, ChurchGM, GilletteMA, CarrSA: PEPPeR, a platform for experimental proteomic pattern recognition.Mol. Cell Proteomics5(10), 1927–1941 (2006).
  • Kreunin P , ZhaoJ, RosserC, UrquidiV, LubmanDM, GoodisonS: Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.J. Proteome Res.6(7), 2631–2639 (2007).
  • Wang L , LiF, SunWet al.: Concanavalin A-captured glycoproteins in healthy human urine. Mol. Cell Proteomics5(3), 560–562 (2006).
  • Pan S , WangY, QuinnJFet al.: Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J. Proteome Res.5(10), 2769–2779 (2006).
  • Ramachandran P , BoontheungP, XieY, SondejM, WongDT, LooJA: Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry.J. Proteome Res.5(6), 1493–1503 (2006).
  • Shaw JL , SmithCR, DiamandisEP: Proteomic analysis of human cervico-vaginal fluid.J. Proteome Res.6(7), 2859–2865 (2007).
  • Pan S , ZhuD, QuinnJFet al.: A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics7(3), 469–473 (2007).
  • Rai AJ , GelfandCA, HaywoodBCet al.: HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics5(13), 3262–3277 (2005).
  • Tammen H , SchulteI, HessRet al.: Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics5(13), 3414–3422 (2005).
  • Tammen H , SchulteI, HessR, MenzelC, KellmannM, Schulz-KnappeP: Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics.Comb. Chem. High Throughput Screen.8(8), 725–733 (2005).
  • Chertov O , BiragynA, KwakLWet al.: Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry. Proteomics4(4), 1195–1203 (2004).
  • Geho DH , LiottaLA, PetricoinEF, ZhaoW, AraujoRP: The amplified peptidome: the new treasure chest of candidate biomarkers.Curr. Opin. Chem. Biol.10(1), 50–55 (2006).
  • Liu T , QianWJ, GritsenkoMAet al.: Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res.4(6), 2070–2080 (2005).
  • Zhang H , YiEC, LiXJet al.: High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell Proteomics4(2), 144–155 (2005).
  • Zhang H , LiXJ, MartinDB, AebersoldR: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.Nat. Biotechnol.21(6), 660–666 (2003).
  • Drake RR , SchweglerEE, MalikGet al.: Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell Proteomics5(10), 1957–1967 (2006).
  • Comunale MA , MattuTS, LowmanMAet al.: Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics4(3), 826–838 (2004).
  • Hathout Y : Approaches to the study of the cell secretome.Expert Rev. Proteomics4(2), 239–248 (2007).
  • Celis JE , GromovP, CabezonTet al.: Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell Proteomics3(4), 327–344 (2004).
  • Martin DB , GiffordDR, WrightMEet al.: Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium. Cancer Res.64(1), 347–355 (2004).
  • Zwickl H , TraxlerE, StaettnerSet al.: A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis26(14), 2779–2785 (2005).
  • Volmer MW , StuhlerK, ZapatkaMet al.: Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics5(10), 2587–2601 (2005).
  • Xiao T , YingW, LiLet al.: An approach to studying lung cancer-related proteins in human blood. Mol. Cell Proteomics4(10), 1480–1486 (2005).
  • Celis JE , MoreiraJM, CabezonTet al.: Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell Proteomics4(4), 492–522 (2005).
  • Gronborg M , KristiansenTZ, IwahoriAet al.: Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.Mol. Cell Proteomics5(1), 157–171 (2006).
  • Khwaja FW , SvobodaP, ReedM, PohlJ, PyrzynskaB, Van MeirEG: Proteomic identification of the wt-p53-regulated tumor cell secretome.Oncogene25(58), 7650–7661 (2006).
  • Pellitteri-Hahn MC , WarrenMC, DidierDNet al.: Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells.J. Proteome Res.5(10), 2861–2864 (2006).
  • Mbeunkui F , FodstadO, PannellLK: Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.J. Proteome Res.5(4), 899–906 (2006).
  • Huang LJ , ChenSX, HuangYet al.: Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer54(1), 87–94 (2006).
  • Chen Y , ZhangH, XuAet al.: Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer54(1), 95–102 (2006).
  • Chevallet M , DiemerH, VanDA, VilliersC, RabilloudT: Toward a better analysis of secreted proteins: the example of the myeloid cells secretome.Proteomics7(11), 1757–1770 (2007).
  • Pardo M , GarciaA, AntrobusR, BlancoMJ, DwekRA, ZitzmannN: Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.J. Proteome Res.6(7), 2802–2811 (2007).
  • Gross M , TopI, LauxIet al.: β-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer. Clin. Cancer Res.13(7), 1979–1986 (2007).
  • Sze SK , de KleijnDP, LaiRCet al.: Elucidating the secretion proteome of human ESC-derived mesenchymal stem cells.Mol. Cell Proteomics6(10), 1680–1689 (2007).
  • Sardana G , MarshallJ, DiamandisEP: Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium.Clin. Chem.53(3), 429–437 (2007).
  • Kim SW , CheonK, KimCHet al.: Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method. Cancer Res.67(14), 6565–6573 (2007).
  • Mbeunkui F , MetgeBJ, ShevdeLA, PannellLK: Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.J. Proteome Res.6(8), 2993–3002 (2007).
  • Kulasingam V , DiamandisEP: Proteomic analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.Mol. Cell Proteomics6(11), 1997–2011 (2007).
  • Li H , DesouzaLV, GhannySet al.: Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography/tandem mass spectrometry. J. Proteome Res.6(7), 2615–2622 (2007).
  • Alvarez-Llamas G , SzalowskaE, de VriesMPet al.: Characterization of the human visceral adipose tissue secretome.Mol. Cell Proteomics6(4), 589–600 (2007).
  • Zvonic S , LefevreM, KilroyGet al.: Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol. Cell Proteomics6(1), 18–28 (2007).
  • Kohn EC , TraversLA, KassisJ, BroomeU, KlominekJ: Malignant effusions are sources of fibronectin and other promigratory and proinvasive components.Diagn. Cytopathol.33(5), 300–308 (2005).
  • Portelius E , Westman-BrinkmalmA, ZetterbergH, BlennowK: Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.J. Proteome Res.5(4), 1010–1016 (2006).
  • Portelius E , ZetterbergH, AndreassonUet al.: An Alzheimer‘s disease-specific β-amyloid fragment signature in cerebrospinal fluid. Neurosci. Lett.409(3), 215–219 (2006).
  • Anderson L , HunterCL: Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.Mol. Cell Proteomics5(4), 573–588 (2006).
  • Liao H , WuJ, KuhnEet al.: Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum.50(12), 3792–3803 (2004).
  • Anderson NL , AndersonNG, HainesLR, HardieDB, OlafsonRW, PearsonTW: Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).J. Proteome Res.3(2), 235–244 (2004).
  • Whiteaker JR , ZhaoL, ZhangHYet al.: Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem.362(1), 44–54 (2007).
  • Gillette MA , ManiDR, CarrSA: Place of pattern in proteomic biomarker discovery.J. Proteome Res.4(4), 1143–1154 (2005).
  • Rifai N , GilletteMA, CarrSA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility.Nat. Biotechnol.24(8), 971–983 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.